Can-Fite BioPharma Ltd. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Can-Fite BioPharma Ltd. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2018 to Q4 2023.
  • Can-Fite BioPharma Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was -$158M, a 5.06% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 -$158M -$7.63M -5.06% Dec 31, 2023 20-F 2024-03-28
Q2 2023 -$155M -$9.77M -6.72% Jun 30, 2023 6-K 2023-08-31
Q4 2022 -$151M -$10.2M -7.23% Dec 31, 2022 20-F 2024-03-28
Q2 2022 -$145M -$14.7M -11.3% Jun 30, 2022 6-K 2022-08-25
Q4 2021 -$141M -$15.2M -12.1% Dec 31, 2021 20-F 2023-03-30
Q2 2021 -$131M -$11.3M -9.48% Jun 30, 2021 6-K 2021-08-26
Q4 2020 -$125M -$15.2M -13.7% Dec 31, 2020 20-F 2022-03-24
Q2 2020 -$119M Jun 30, 2020 6-K 2020-08-27
Q4 2019 -$110M -$12.6M -12.9% Dec 31, 2019 20-F 2021-03-25
Q4 2018 -$97.7M Dec 31, 2018 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.